Cargando…

Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy

In the treatment of cancers, small interfering ribonucleic acids (siRNAs) are delivered into cells to inhibit the oncogenic protein’s expression; however, polyanions, hydrophilicity, and rapid degradations in blood, endosomal or secondary lysosomal degradation hamper clinal applications. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Shiou-Fen, Wen, Yu-Han, Yu, Lu-Yi, Chiu, Hsin-Cheng, Chiang, Yi-Ting, Lo, Chun-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198952/
https://www.ncbi.nlm.nih.gov/pubmed/34072925
http://dx.doi.org/10.3390/polym13111823
_version_ 1783707261403660288
author Hung, Shiou-Fen
Wen, Yu-Han
Yu, Lu-Yi
Chiu, Hsin-Cheng
Chiang, Yi-Ting
Lo, Chun-Liang
author_facet Hung, Shiou-Fen
Wen, Yu-Han
Yu, Lu-Yi
Chiu, Hsin-Cheng
Chiang, Yi-Ting
Lo, Chun-Liang
author_sort Hung, Shiou-Fen
collection PubMed
description In the treatment of cancers, small interfering ribonucleic acids (siRNAs) are delivered into cells to inhibit the oncogenic protein’s expression; however, polyanions, hydrophilicity, and rapid degradations in blood, endosomal or secondary lysosomal degradation hamper clinal applications. In this study, we first synthesized and characterized two copolymers: methoxy poly(ethylene glycol)-b-poly(2-hydroxy methacrylate-ketal-pyridoxal) and methoxy poly(ethylene glycol)-b-poly(methacrylic acid-co-histidine). Afterwards, we assembled two polymers with the focal adhesion kinase (FAK) siRNA, forming polyplex-mixed micelles for the treatment of the human colon cancer cell line HCT116. In terms of the physiological condition, the cationic pyridoxal molecules that were conjugated on the copolymer with ketal bonds could electrostatically attract the siRNA. Additionally, the pyridoxal could form a hydrophobic core together with the hydrophobic deprotonated histidine molecules in the other copolymer and the hydrophilic polyethylene glycol (PEG) shell to protect the siRNA. In an acidic condition, the pyridoxal would be cleaved from the polymers due to the breakage of the ketal bonds and the histidine molecules can simultaneously be protonated, resulting in the endosome/lysosome escape effect. On the basis of our results, the two copolymers were successfully prepared and the pyridoxal derivatives were identified to be able to carry the siRNA and be cleavable by the copolymers in an acidic solution. Polyplex-mixed micelles were prepared, and the micellar structures were identified. The endosome escape behavior was observed using a confocal laser scanning microscopy (CLSM). The FAK expression was therefore reduced, and the cytotoxicity of siRNA toward human colon cancer cells was exhibited, rapidly in 24 h. This exceptional anticancer efficiency suggests the potential of the pH-sensitive polyplex-mixed micellar system in siRNA delivery.
format Online
Article
Text
id pubmed-8198952
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81989522021-06-14 Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy Hung, Shiou-Fen Wen, Yu-Han Yu, Lu-Yi Chiu, Hsin-Cheng Chiang, Yi-Ting Lo, Chun-Liang Polymers (Basel) Article In the treatment of cancers, small interfering ribonucleic acids (siRNAs) are delivered into cells to inhibit the oncogenic protein’s expression; however, polyanions, hydrophilicity, and rapid degradations in blood, endosomal or secondary lysosomal degradation hamper clinal applications. In this study, we first synthesized and characterized two copolymers: methoxy poly(ethylene glycol)-b-poly(2-hydroxy methacrylate-ketal-pyridoxal) and methoxy poly(ethylene glycol)-b-poly(methacrylic acid-co-histidine). Afterwards, we assembled two polymers with the focal adhesion kinase (FAK) siRNA, forming polyplex-mixed micelles for the treatment of the human colon cancer cell line HCT116. In terms of the physiological condition, the cationic pyridoxal molecules that were conjugated on the copolymer with ketal bonds could electrostatically attract the siRNA. Additionally, the pyridoxal could form a hydrophobic core together with the hydrophobic deprotonated histidine molecules in the other copolymer and the hydrophilic polyethylene glycol (PEG) shell to protect the siRNA. In an acidic condition, the pyridoxal would be cleaved from the polymers due to the breakage of the ketal bonds and the histidine molecules can simultaneously be protonated, resulting in the endosome/lysosome escape effect. On the basis of our results, the two copolymers were successfully prepared and the pyridoxal derivatives were identified to be able to carry the siRNA and be cleavable by the copolymers in an acidic solution. Polyplex-mixed micelles were prepared, and the micellar structures were identified. The endosome escape behavior was observed using a confocal laser scanning microscopy (CLSM). The FAK expression was therefore reduced, and the cytotoxicity of siRNA toward human colon cancer cells was exhibited, rapidly in 24 h. This exceptional anticancer efficiency suggests the potential of the pH-sensitive polyplex-mixed micellar system in siRNA delivery. MDPI 2021-05-31 /pmc/articles/PMC8198952/ /pubmed/34072925 http://dx.doi.org/10.3390/polym13111823 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hung, Shiou-Fen
Wen, Yu-Han
Yu, Lu-Yi
Chiu, Hsin-Cheng
Chiang, Yi-Ting
Lo, Chun-Liang
Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy
title Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy
title_full Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy
title_fullStr Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy
title_full_unstemmed Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy
title_short Development of a Rapid-Onset, Acid-Labile Linkage Polyplex-Mixed Micellar System for Anticancer Therapy
title_sort development of a rapid-onset, acid-labile linkage polyplex-mixed micellar system for anticancer therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198952/
https://www.ncbi.nlm.nih.gov/pubmed/34072925
http://dx.doi.org/10.3390/polym13111823
work_keys_str_mv AT hungshioufen developmentofarapidonsetacidlabilelinkagepolyplexmixedmicellarsystemforanticancertherapy
AT wenyuhan developmentofarapidonsetacidlabilelinkagepolyplexmixedmicellarsystemforanticancertherapy
AT yuluyi developmentofarapidonsetacidlabilelinkagepolyplexmixedmicellarsystemforanticancertherapy
AT chiuhsincheng developmentofarapidonsetacidlabilelinkagepolyplexmixedmicellarsystemforanticancertherapy
AT chiangyiting developmentofarapidonsetacidlabilelinkagepolyplexmixedmicellarsystemforanticancertherapy
AT lochunliang developmentofarapidonsetacidlabilelinkagepolyplexmixedmicellarsystemforanticancertherapy